What conditions have the most trials recruiting in Sanming, China?

In Sanming, China, the conditions with the most recruiting trials are Bevacizumab (1), Breast Neoplasms (1), Breast cancer (1).

Clinical trials recruiting in Sanming, China

Recruiting trials

Conditions

Phase 2 1Not applicable 2

Condition	Trials
Bevacizumab	1
Breast Neoplasms	1
Breast cancer	1
Cardiovascular Diseases	1
Colo-rectal Cancer	1
Colorectal cancer	1
Diabetes Mellitus Type 2	1
HR+/HER2- Breast Cancer	1
Hypertension	1
TAS 102	1
Third-line and Beyond Therapy	1
Type 2 diabetes	1

County Medical Community-based, Cardiovascular Risk Stratified Integrated Care Model: a Pragmatic Cluster Randomised Control Trial
NCT06302127 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 70 Years · Sex: All (male and female)
Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
NCT07085169 · Phase: Phase 2 · Ages: 60 Years and older · Sex: All (male and female)
Pre-Treatment DCE-MRI AI Models Predict Neoadjuvant Chemotherapy Response in HR+/HER2- Breast Cancer
NCT07702708 · Phase: Not specified · Ages: 18 Years and older · Sex: Female

3 recruiting trials have at least one study site in Sanming, China.

No. For the full record, search ClinicalTrials.gov.